ADEMEX: the evidence and the nephrosopher

Affiliations

Comment

Salim Mujais et al. Perit Dial Int. 2007 May-Jun.

. 2007 May-Jun;27(3):234-7.

¹ Baxter Healthcare Corporation, 1620 Waukegan Road, McGaw Park, IL 60085, USA. salim_mujais@baxter.com

No abstract available

Comment on

Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial.
Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S. Paniagua R, et al. J Am Soc Nephrol. 2002 May;13(5):1307-1320. doi: 10.1681/ASN.V1351307. J Am Soc Nephrol. 2002. PMID: 11961019 Clinical Trial.
Health-related quality of life predicts outcomes but is not affected by peritoneal clearance: The ADEMEX trial.
Paniagua R, Amato D, Vonesh E, Guo A, Mujais S; Mexican Nephrology Collaborative Study Group. Paniagua R, et al. Kidney Int. 2005 Mar;67(3):1093-104. doi: 10.1111/j.1523-1755.2005.00175.x. Kidney Int. 2005. PMID: 15698450 Clinical Trial.